Lundbeck sells $100m portfolio
January 22, 2013Sales and Marketing Lundbeck, OTC, Panhematin, Recordati
Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …
New appointment and promotions at Events 4 Healthcare
January 22, 2013Medical Communications, Sales and Marketing Events 4 Healthcare
Comms agency Events 4 Healthcare has announced two new promotions and a new appointment to further enhance its team. Nicola …
Novartis eye drug nears approval
January 21, 2013Sales and Marketing AMD, CHMP, Jetria, Novartis
Novartis’ eye drug Jetrea has been given a positive opinion by the CHMP, pushing it to the brink of approval. …
CHMP nod for Pfizer CML drug
January 21, 2013Sales and Marketing CHMP, CML, FDA, Pfizer
Pfizer’s cancer drug bosutinib has been given a positive opinion by the CHMP for patients with chronic myelogenous leukemia (CML). …
Crohn’s and Colitis UK hire new chief executive
January 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Crohn's and Colitis, David Barker
The medical charity Crohn’s and Colitis UK Trustees have announced the appointment of David Barker as the new chief executive …
EU nod for Lilly brain diagnostic
January 18, 2013Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly
Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …
Roche’s Burgess to head up discovery at BMS
January 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Burgess
Bristol-Myers Squibb has appointed Mike Burgess as senior vice president, Discovery Medicine and Clinical Pharmacology. He will report to Francis …
Amgen earmarks $200m for new Singapore plant
January 18, 2013Manufacturing and Production Amgen, Merck, Singapore
Amgen has unveiled plans to construct a new manufacturing plant in Singapore, its first production facility in Asia. The biotechnology …
Biogen and Elan file for Tysabri first line use in MS
January 18, 2013Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya
Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …
MPs: ‘get on with VBP’
January 18, 2013Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …
Senior sales appointment at Rieke Dispensing
January 18, 2013Manufacturing and Production, Research and Development, Sales and Marketing Nicolas Lemaigre-Voreaux, Rieke Dispensing
Packaging firm Rieke Dispensing has appointed Nicolas Lemaigre-Voreaux as its European Sales director to spearhead the company’s growth programme. Lemaigre-Voreaux …
Go digital health launched
January 17, 2013Medical Communications GolinHarris, Virgo, go digital health
A new global digital practice, go digital health, has been launched by Virgo Health and GolinHarris. The team brings together …
EMA issues draft guidance on shared facility risks
January 17, 2013Manufacturing and Production EMA, manufacturing
The European Medicines Agency has issued draft guidance to help drug manufacturers avoid cross-contamination of products made in shared facilities. …
Bayer cleared of Xarelto ‘breaches’
January 17, 2013Medical Communications, Sales and Marketing Bayer, PMCPA, Xarelto
Bayer has been found not guilty of making multiple breaches of the ABPI Code of Practice following an anonymous complaint …
Scotland fund for rare diseases
January 17, 2013Sales and Marketing SMC, Scotland, rare diseases
The Scottish government is launching a £21 million fund in March to meet the costs of patients who require orphan …
MSI appoints senior consultant
January 17, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Watson, MSI Consultancy
Strategic pharma marketing consultancy firm The MSI Consultancy has appointed David Watson as a senior consultant, specialising in channel strategy. …
Private equity firm pays $212m for Cambridge Major Labs
January 16, 2013Manufacturing and Production American Capital, CML, Cambridge
Private equity firm American Capital has said it will pay $212 million to buy out Cambridge Major Laboratories (CML), a …
The price of innovation
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP
One of the strange paradoxes of our industry is that we have a very large number of new medicines in …
AstraZeneca shakes up management
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot
AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …
Sanofi Pasteur MSD appoint president of Vaccines Europe
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrea Rappagliosi, Sanofi pasteur msd, vaccines
Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
